Purchases and Sales Made in Q4 2025 in Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS) during Q4 2025. The information is specifically focused on institutions that hold shares of Corvus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 16, 2026
Q4 2025
|
Tema Etfs LLC
New York, NY |
BUY
|
- |
20.5K+ 34.62% |
$138K - $180K
|
79.7K
$699K
|
|
|
Jan 09, 2026
Q4 2025
|
Sg Americas Securities, LLC
|
BUY
|
- |
20KNew |
$135K - $176K
|
20K
$176K
|
|
|
Jan 20, 2026
Q4 2025
|
Sowell Financial Services LLC
North Little Rock, AR |
BUY
|
- |
5K+ 41.67% |
$33.7K - $43.9K
|
17K
$149K
|
|
|
Jan 02, 2026
Q4 2025
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
49+ 52.13% |
$330 - $430
|
143
$1.25K
|
|
|
Jan 15, 2026
Q4 2025
|
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
|
SELL
|
- |
-1.8K- 1.06% |
$12.1K - $15.8K
|
167K
$1.47M
|
|